About Renare
About Renare Medical

Company Profile

Tsing Tao Renare Medical Technologies Co. Ltd.

Tsing Tao Renare Medical Technologies Co. Ltd. was registered and established in Qingdao, China, in March 2019. It is a Sino-foreign joint venture introduced to Chengyang District, Qingdao.

The company has an experienced international management and R&D team, integrating R&D, production, and sales. Its products cover comprehensive renal care, including liquid and oral solid preparations, biologics, nutritional products, high-end medical devices, AI management solutions, and high-value-added APIs, serving kidney disease patients worldwide.

Using advanced international technologies, the company develops high-end medical products to benefit kidney disease patients in China and overseas. It aims to become a world-leading multinational company in renal care and therapy!

Renare Medical
CULTURE

Corporate Culture

Our Mission
Improve quality of life, save lives and advance kidney health through innovative technologies and high-quality products
Our Vision
Become a globally recognized multinational leader in comprehensive kidney-disease treatment and care
Our Goal
Provide high-quality kidney-disease treatment and care products worldwide
Core Values
Quality First, Patients Above All, Innovation, Collaboration, Candor and Integrity, Lifelong Learning
Quality Policy
Technological Innovation, Quality First, Continuous Improvement and Sustainable Development

Renare Product Portfolio

Based in China, Serving the World
To become the world’s only high-tech company integrating R&D, manufacturing and sales across the full spectrum of renal-care products, including liquid formulations, oral solid formulations, biologics, nutritional products and high-value active pharmaceutical ingredients.
Milestones
2019.03
Renare Medical established
2021.08
Drug manufacturing license obtained
2023.02
Passed GMP compliance inspection
2023.06
API change approval obtained
2023.10
Peritoneal dialysis solution registration approved
2024.11
Certified as a National High-Tech Enterprise
2026.05
Recognized as an Innovative SME
2026.08
Recognized as a Specialized, Sophisticated, Distinctive and Innovative SME